Bio Protocol
21 employees on LinkedIn · 12 known investors
Bio Protocol is a decentralized science (DeSci) platform where people can fund, develop and govern tokenized early-stage scientific research from universities, companies and researchers. It offers token-based fundraising, staking rewards, and a scientific AI agent framework, supporting an ecosystem of biotech DAOs focused on areas such as longevity, women's health, and rare diseases.
Investors · 12
Binance Labs✓ verifiedMalta · $100K – $5M
Pfizer Ventures✓ verified
Big Brain HoldingsLos Angeles
Polymorphic Capital
SerafundVancouver
Signature VenturesAying
SMAPE CapitalCologne
Sora VenturesTaipei
Animoca Brandsreported · 2 sourcesHong Kong · $1.5M – $40M
Mechanism Capitalreported · 2 sourcesLiberty Hill · $2M – $22M
Also in the syndicate · 2
Maelstrom FundleadPresto Labs
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundAug 2026
Maelstrom Fund (lead), Animoca Brands, Mechanism Capital
Source ↗ - Undisclosed amountseed fundingSep 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Bio Protocol do?
- Bio Protocol is a decentralized science (DeSci) platform where people can fund, develop and govern tokenized early-stage scientific research from universities, companies and researchers. It offers token-based fundraising, staking rewards, and a scientific AI agent framework, supporting an ecosystem of biotech DAOs focused on areas such as longevity, women's health, and rare diseases.
- Who are Bio Protocol's investors?
- Bio Protocol's investors include Binance Labs, Pfizer Ventures, Big Brain Holdings, Polymorphic Capital, Serafund, Signature Ventures, SMAPE Capital, Sora Ventures and 2 more.